Innovative Research Award
Youssouf Sereme
Center for Research on Inflammation (CRI) (INSERM U1149), Paris, France
| Youssouf Sereme |
| Affiliation |
Center for Research on Inflammation (CRI) (INSERM U1149) |
| Country |
France |
| Scopus ID |
57204474299 |
| Documents |
32 |
| Citations |
504 |
| h-index |
13 |
| Subject Area |
Immunology and Microbiology |
| Event |
International Phenomenological Research Awards |
| ORCID |
0000-0002-5607-1460 |
Youssouf Sereme, PhD, HDR is a French postdoctoral researcher specializing in immunology, microbiology and translational vaccinology. His scientific activities focus on infectious diseases, mucosal immunity, microbiota-host interactions, neonatal bacterial infections and vaccine development. His scholarly record includes internationally indexed publications, multidisciplinary collaborations and translational innovations supporting advances in infectious disease prevention and immunological research.[1]
Abstract
Youssouf Sereme has established an academic profile in infectious disease immunology through research integrating microbiology, vaccinology and host-pathogen interactions. His work addresses bacterial vaccines, neonatal infections, allergic disease biomarkers, microbiota-associated immunity and translational biomedical science while promoting international scientific collaboration and evidence-based innovation.[1]
Keywords
Immunology, Microbiology, Vaccinology, Vaccine Development, Escherichia coli, HIV, Allergy, Host Response, Microbiota, Infectious Diseases.
Introduction
His academic journey spans Jean Monnet University, Claude Bernard University Lyon 1, Aix-Marseille University and INSERM. Research activities have included studies on HIV reservoirs, neonatal immunity, microbiota-associated immune regulation, bacterial vaccinology and emerging infectious diseases, contributing to translational biomedical research with international relevance.[2]
Research Profile
Currently affiliated with INSERM U1149 in Paris, Youssouf Sereme investigates immune signalling, bacterial vaccine development and mucosal immunity. His collaborations extend across France, Brazil, Mali, Senegal, Congo, the United States and other international institutions. His research portfolio includes over thirty peer-reviewed publications and an international vaccine patent.[1]
Research Contributions
Major contributions include development of live attenuated bacterial vaccines targeting neonatal Escherichia coli K1 meningitis and Pseudomonas aeruginosa infections, investigations into Th17 and IgA-mediated immunity, microbiota-host interactions, immunological biomarkers of allergy, and translational infectious disease research with potential clinical application.[3]
Publications
Youssouf Sereme has authored influential peer-reviewed publications spanning infectious disease immunology, microbiota-host interactions, allergy, COVID-19 biomarkers, rheumatology, fungal exposome research and One Health. His studies demonstrate strong translational relevance, contributing to vaccine development, immune response characterization and infectious disease prevention through internationally recognized scientific journals.[3][4][5][6][7]
Research Impact
With a Scopus Documents 32, h-index of 13, over 504 citations and multidisciplinary collaborations, Youssouf Sereme’s research contributes to vaccine innovation, infectious disease prevention and immunological understanding. His translational investigations bridge laboratory discoveries with clinically relevant applications supporting future therapeutic development.[1]
Youssouf Sereme’s research has strengthened translational vaccinology, infectious disease immunology and microbiota science through widely cited publications, international collaborations and innovative vaccine development, contributing to improved prevention strategies and measurable scientific impact.[1][2]
Award Suitability
The research profile demonstrates sustained scientific productivity, international collaboration, translational innovation and measurable scholarly influence. Contributions to bacterial vaccinology, infectious disease immunology and microbiota research align well with recognition through the International Phenomenological Research Awards for advancing impactful biomedical research.[2]
Conclusion
Youssouf Sereme represents a contemporary biomedical researcher whose work integrates immunology, microbiology and vaccinology to address major infectious disease challenges. His combination of scientific publications, translational vaccine research, international partnerships and scholarly impact reflects a distinguished and continually developing academic career.[1]
External Links
References
- Elsevier. (n.d.). Scopus Author Details: Dr. Youssouf SEREME, Author ID 57204474299. Scopus. https://www.scopus.com/authid/detail.uri?authorId=57204474299
- ORCID. (n.d.). Dr. Youssouf SEREME – ORCID Research Profile. https://orcid.org/0000-0002-5607-1460
- Sereme Y, Vitte J, Diallo AB, Boumaza A, Lopez A, Michel M, et al. A granulocytic signature identifies COVID-19 and its severity. Journal of Infectious Diseases. https://academic.oup.com/jid/article/222/12/1985/5907982
- Mezouar S, Sereme Y, Chantran Y, Michel J, Fabre A, et al. Microbiome and the immune system: From a healthy steady-state to allergy associated disruption. Human Microbiome Journal. https://doi.org/10.1016/j.humic.2018.10.001
- Moulin D, Sereme Y, Millard M, Taïeb M, Michaudel C, et al. Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard-2023-224014
- Vitte J, Michel M, Sereme Y, Malinovschi A, Caminati M, et al. Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergy. Allergy. https://doi.org/10.1111/all.15483
- Laidoudi Y, Sereme Y, Medkour H, Watier-Grillot S, et al. SARS-CoV-2 antibodies seroprevalence in dogs from France using ELISA and an automated western blotting assay. One Health. https://doi.org/10.1016/j.onehlt.2021.100293